Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-4382

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-4382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pantoprazole Structural Formula (8f0bbcb2 8643 41a9 B9fd A5f25a7dba5d 01)

Pantoprazole Structural Formula (8f0bbcb2 8643 41a9 B9fd A5f25a7dba5d 01)
Chemical structure of pantoprazole sodium, the active ingredient in Pantoprazole Sodium 40 mg delayed-release tablets by Cardinal Health 107, LLC. The diagram shows the molecular arrangement including sodium ion, fluorine atoms, methoxy groups, and other chemical bonds relevant to the molecule.*
FDA Label Image

40mg Bag Label (3a875ad3 8a73 B446 E063 6294a90a1a63 00)

40mg Bag Label (3a875ad3 8a73 B446 E063 6294a90a1a63 00)
Label for Pantoprazole Sodium delayed-release tablets, USP 40 mg, containing 10 tablets. Tablets are described as dark yellow, oval, and unscored with imprint "M P9." Manufactured for Mylan Pharmaceuticals Inc. and distributed by Mylan Institutional Inc. and Cardinal Health. Storage and usage warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.